EUVIMEDEUVIMED entdecken
Crossref

Anti-infective therapy of inhibiting Staphylococcus aureus ClpP by protocatechuic aldehyde

Shufang Li, Hongfa Lv, Yonglin Zhou, Jianfeng Wang, Xuming Deng, Hongxia Ma, Lingcong Kong, Yan Zhang, Qiaoling Zhang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Shufang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Staphylococcus aureus, Staphylococcal Infections, Benzaldehydes, Endopeptidase Clp. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jilin University, Education Department of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing antibiotic resistance and widespread pathogenicity of Staphylococcus aureus (S. aureus) has resulted in severe infections in both human and animals, necessitating the urgent development of novel therapeutic agents. Targeting virulence factors has emerged as a promising approach to combat infections caused by drug-resistant bacteria. Protocatechuic aldehyde (PCA) was identified as an inhibitor of S. aureus ClpP through an enzyme activity inhibition assay. Treatment with PCA at concentrations of 64 and 128 μg/mL significantly reduced the proteolytic and hemolytic activities of S. aureus, as well as its adherence and invasion capabilities. Furthermore, S. aureus treated with PCA exhibited decreased persistence under adverse stress conditions, including elevated temperature, NaClO, and H₂O₂ stress. Furthermore, the bactericidal activity of tigecycline against S. aureus was enhanced when used in combination with PCA. Molecular simulations revealed that PCA directly binded to ClpP at the G107, V88, and I81 residues, thereby further inhibiting its activity. In vivo, PCA treatment improved survival rates and reduced inflammatory responses in a mouse model of S. aureus-induced pneumonia. Overall, PCA represents an effective therapeutic agent against S. aureus infections by inhibiting ClpP activity, providing a novel strategy to combat S. aureus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusStaphylococcal InfectionsBenzaldehydesEndopeptidase ClpAnti-Bacterial AgentsBacterial ProteinsCatecholsAnimalsMiceHumansFemaleDisease Models, AnimalMice, Inbred BALB C

Stichwörter der Autor:innen

ClpPProtocatechuic aldehyde, anti-infectionS. aureus

Substanzen

BenzaldehydesEndopeptidase ClpprotocatechualdehydeAnti-Bacterial AgentsBacterial ProteinsCatechols

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
  • Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, School of Life Sciences, Ningxia University, Yinchuan, China.
  • College of Life Science, Jilin Agricultural University, 130118 Changchun, China.
  • Hospital of Stomatology, Jilin University, Changchun 130062, China. Electronic address: zhangyan330201@jlu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Jilin University
  • Education Department of Jilin Province
  • Jilin Provincial Natural Science Foundation

Zitieren

APA

Li, S., Lv, H., Zhou, Y., Wang, J., Deng, X., Ma, H., Kong, L., Zhang, Y., & Zhang, Q. (2025). Anti-infective therapy of inhibiting Staphylococcus aureus ClpP by protocatechuic aldehyde. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114802

Vancouver

Li S, Lv H, Zhou Y, Wang J, Deng X, Ma H, et al. Anti-infective therapy of inhibiting Staphylococcus aureus ClpP by protocatechuic aldehyde. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114802

BibTeX
@article{Li2025,
  author = {Li, Shufang and Lv, Hongfa and Zhou, Yonglin and Wang, Jianfeng and Deng, Xuming and Ma, Hongxia and Kong, Lingcong and Zhang, Yan and Zhang, Qiaoling},
  title = {Anti-infective therapy of inhibiting Staphylococcus aureus ClpP by protocatechuic aldehyde},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114802}
}
Kostenlos starten →